Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 1:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 971 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control (standard practice) Clear all

Conditions: Healthy, Covert Consciousness
Interventions: Dexmedetomidine (+propofol as indicated), Ketamine; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 40 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Anxiety, Depression, Problem Behavior
Interventions: psychotherapy, evidence-based treatment, modular evidence-based treatment; Behavioral
Lead sponsor: Judge Baker Children's Center; Other
Eligibility: 7 Years to 13 Years
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 2
States / cities: Honolulu, Hawaii • Boston, Massachusetts

Conditions: Respiratory Disease, Inflammation, Insufficient Sleep, Digestive Disease, Skin Conditions, Body Mass Index, Infections, Allergies, Congestion, Antibiotic Use, Overweight and Obesity
Interventions: Attachment and Biobehavioral Catch-Up, Home-Based Book-of-the-Week; Behavioral · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 8 Months to 12 Months
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Anesthesia; Adverse Effect
Interventions: Routine opioid management, PMD-200 Nol-guided opioid administration; Drug · Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 21 Years to 85 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hand Hygiene
Interventions: Provodine Hand Sanitizer; Drug
Lead sponsor: Sundara Reddy; Other
Eligibility: 22 Years to 65 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Bacteremia, Fungemia, Bloodstream Infection
Interventions: FilmArray testing, Antimicrobial Stewardship, Bacterial culture, Susceptibility testing; Device · Behavioral · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: Up to 99 Years
Enrollment: 743 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Chronic Pain, Opioid-Related Disorders
Interventions: Electronic decision support tools, Enhanced patient education materials, Nurse care management, Electronic Patient Registry, Academic detailing; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Diseases, Type 2 Diabetes
Interventions: Educational Materials on the Cardiovascular Disease in Type 2 Diabetes (CVD-T2D), Educational Materials on the CVD-T2D and Bundled Metabolic Panel; Other
Lead sponsor: Qure Healthcare, LLC; Industry
Eligibility: Not listed
Enrollment: 251 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Rotator Cuff Tears
Interventions: Clomiphene Citrate, Rotator Cuff Repair; Drug · Procedure
Lead sponsor: University of Utah; Other
Eligibility: 40 Years to 80 Years · Male only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Emotion Regulation
Interventions: Reflective Supervision Enhancement; Behavioral
Lead sponsor: Bradley Hospital; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Riverside, Rhode Island

Conditions: Pediatric Obesity
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 10 Years to 18 Years
Enrollment: 295 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Overweight and Obesity, Overweight Adolescents, Emotional Stress, Stress, Psychological, Eating Behavior
Interventions: Mindfulness-Based Weight Control (MBWC), Standard Behavioral Weight Control (SBWC); Behavioral
Lead sponsor: Kent State University; Other
Eligibility: 13 Years to 18 Years
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Kent, Ohio

Conditions: Cancer
Interventions: Social cue prompt and policy, Standard prompts; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 294 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Alertness, Fatigue, Mood, and Performance, Calorie Restriction and Light Intervention
Interventions: Caloric restriction, Light exposure; Behavioral · Device
Lead sponsor: National Aeronautics and Space Administration (NASA); Federal
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Mountain View, California

Conditions: Skin Cancer
Interventions: Sun Safety Ink! Program, Attention Control; Behavioral
Lead sponsor: Klein Buendel, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,820 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Aurora, Colorado • Golden, Colorado

Conditions: Depressive Disorder, Major
Interventions: Esketamine, Placebo, Standard of Care; Drug · Other
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 17
States / cities: Birmingham, Alabama • Chandler, Arizona • Garden Grove, California + 14 more

Conditions: Diabetes Mellitus, Type 1
Interventions: Motivational Enhancement System (MES), Question Prompt List (QPL), Text Message Reminders (TXT); Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 16 Years to 25 Years
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Diabetic Polyneuropathy, Weight Loss
Interventions: Weight Achievement and Intensive Treatment (Why WAIT); Other
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Preeclampsia, Aspirin, Clinical Decision Support Systems, Economics, Behavioral
Interventions: Electronic health record best practice alert; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: Female only
Enrollment: 830 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Tobacco Use, Drug Use, Adolescent Behavior, Alcohol Use, Sexual Risk Behavior
Interventions: S4E, Attention-Matched Control Group; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 13 Years to 21 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Ypsilanti, Michigan

Conditions: Fall Injury
Interventions: facilitative system, Standard Program; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 65 Years and older
Enrollment: 35,037 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Knee Arthroplasty
Interventions: Knee Flexion, Standard Care; Other · Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Herpes Zoster Disease
Interventions: An informational packet regarding shingles and the HZV was sent to patients identified by the EMR; Other
Lead sponsor: Ohio State University; Other
Eligibility: 60 Years and older
Enrollment: 2,589 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category), MDS (Myelodysplastic Syndrome), CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), Prolymphocyctic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasm (MPN), Lymphoma, Myelofibrosis
Interventions: Conditioning Regimen A, Conditioning Regimen B, Conditioning Regimen C, Conditioning Regimen D, Conditioning Regimen E, Hematopoietic Cell Transplantation, PTCy (50 mg/kg D3, D4), PTCy (25 mg/kg D3, D4), Post-transplant Tacrolimus, Post-transplant Mycophenolate mofetil, Post-transplant Abatacept, Post-transplant Ruxolitinib, Supportive Care: Growth Factors, Supportive Care: Blood Products, Supportive Care: Infection Prophylaxis, Supportive Care: Intravenous immune globulin (IVIG), Supportive Care: Seizure prophylaxis, Supportive Care: Monitoring and management of CRS, Supportive Care: Prophylaxis against infections, Supportive Care: Prophylaxis against infections, Supportive Care: Lipid elevations, Study treatment compliance, Prohibited Concomitant Therapy, Permitted Concomitant Therapy; Drug · Procedure · Other
Lead sponsor: Center for International Blood and Marrow Transplant Research; Network
Eligibility: 18 Years to 66 Years
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 13
States / cities: Birmingham, Alabama • Duarte, California • Palo Alto, California + 10 more

Search by objective public record fields.

Assessing Covert Consciousness During Dexmedetomidine and Ketamine Sedation: An fMRI Study

The Clinic Treatment Project

Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention

Postoperative Consequences of Intraoperative NOL Titration

ProvodineTM Decreases Hand Contamination

Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures

Transforming Opioid Prescribing in Primary Care

Clinical Utility Trial for the SomaLogic CVD-T2D Test

Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial

Enhancing Early Care and Education Through Reflective Supervision

Pediatric Obesity Observational Prospective Trial

Healthy Eating, Activity and Reduction of Teen Stress

Social Media Posts About Cancer: Five Timepoints

Fatigue in Long-Haul Operations

Sun Safety Ink! A Sun Safety Program for the Tattoo Community

54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide

Improving Diabetes in Emerging Adulthood

Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy

Low Dose Aspirin Alerts in High-Risk Pregnancies

Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention

Dissemination of Injury Interventions

Knee Positioning After Total Knee Replacement

Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation